IOVANCE BIOTHERAPEUTICS, INC. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure for Q1 2024
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate for Q1 2024.
- Iovance Biotherapeutics, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending March 31, 2024 was 0.21 pure.
- Iovance Biotherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
- Iovance Biotherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
- Iovance Biotherapeutics, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)